There are 1105 resources available
626MO - Tarlatamab in previously treated small cell lung cancer (SCLC): Subgroup analysis of patients from the Asia region in the phase II DeLLphi-301 study
Presenter: Hiroaki Akamatsu
Session: Mini Oral session: Thoracic malignancies
Resources:
Abstract
Slides
Webcast
ESMO Frameworks for biology-informed and primary tumour-agnostic drug development in the era of molecular niches
Presenter: Giuseppe Curigliano
Session: Latest advances/controversies in drug development
Resources:
Slides
Webcast
HER2 inhibition: Agnostic approach or disease-specific strategy?
Presenter: Filippo Pietrantonio
Session: Personalising gastrointestinal (GI) oncology: From old to new target inhibition
Resources:
Slides
Webcast
Early detection and screening for lung cancer in the Asia Pacific region
Presenter: Herbert Ho Fung Loong
Session: Cancer in low- or middle-income countries (LMICs): Challenges to prevention and providing equitable care
Resources:
Slides
Webcast
The applications of artificial intelligence (AI) in the clinical trial lifecycle
Presenter: Benjamin Haibe-Kains
Session: Session in collaboration with AACR - Walkthroughs in clinical trials in the era of molecular oncology
Resources:
Slides
Webcast
463MO - Active treatment in final weeks of life: Importance of palliative care in advanced non-small-cell lung cancer
Presenter: Luis Posado-Domínguez
Session: Mini oral session: Supportive and palliative care
Resources:
Abstract
Slides
Webcast
627MO - POD1UM-304: Phase III study of retifanlimab plus platinum-based chemotherapy (Chemo) as first-line (1L) therapy for nonsquamous or squamous metastatic non–small cell lung cancer (mNSCLC)
Presenter: Shun Lu
Session: Mini Oral session: Thoracic malignancies
Resources:
Abstract
How can collaborative drug matching programmes make the most of genomic profiling for patient benefit?
Presenter: David Thomas
Session: Latest advances/controversies in drug development
Resources:
Slides
Webcast
Targeted options in patients with RAS or BRAF mutant tumours: Not only a colorectal cancer matter
Presenter: Dominik Modest
Session: Personalising gastrointestinal (GI) oncology: From old to new target inhibition
Resources:
Slides
Webcast
Utility of the ESMO Magnitude of Clinical Benefit Scale (MCBS) in high-income countries (HIC) and LMIC, and access to drugs
Presenter: Aju Mathew
Session: Cancer in low- or middle-income countries (LMICs): Challenges to prevention and providing equitable care
Resources:
Slides
Webcast